MAIA Biotechnology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $20,182,381.
Profit Margin
| 2019 | 0 | -6.49M | |
|---|---|---|---|
| 2020 | 0 | -6.66M | |
| 2021 | 0 | -13.28M | |
| 2022 | 0 | -15.80M | |
| 2023 | 0 | -19.77M |
MAIA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 11.11M | 8.61M | 3.45M | 1.41M | 1.91M |
Selling and marketing | 0 | 0 | 0 | 0 | 5.00M |
Total operating expenses | 20.18M | 15.86M | 7.74M | 6.97M | 6.92M |
Operating income | -20.18M | -16.17M | -7.78M | -6.97M | -6.92M |
Other income (expenses), net | 409.47K | 406.92K | -4.79M | 16.35K | 246 |
Income before tax | -19.77M | -15.76M | -12.57M | -6.95M | -6.92M |
Income tax expense | 0 | 36.68K | 707.53K | -291.04K | -435.25K |
Net income | -19.77M | -15.80M | -13.28M | -6.66M | -6.49M |
Earnings per share | |||||
Basic EPS | -1.49 | -1.7 | -1.25 | -0.63 | -0.61 |
Diluted EPS | -1.49 | -1.7 | -1.25 | -0.63 | -0.61 |
| Data source | Data source |